文献速递皮肤肿瘤

皮肤鳞状细胞癌进展的基因表达图景

Gene expression landscape of cutaneous squamous cell carcinoma progression.
PubMed 文献 · Br J Dermatol · 2024-01-01

该研究通过荟萃分析统一处理公开RNA-Seq数据,涵盖73例临床正常皮肤、46例光化性角化病、16例原位SCC、13例角化棘皮瘤和147例cSCC样本,定义了从正常皮肤到cSCC进展的共识差异表达基因集,并揭示免疫抑制患者cSCC中记忆B细胞和CD8+ T细胞减少,基因融合并非cSCC常见驱动因素。

要点

  • cSCC进展存在共识差异表达基因集,部分基因在癌前阶段已改变。
  • 免疫抑制患者cSCC中记忆B细胞和CD8+ T细胞较免疫正常者减少。
  • 基因融合在cSCC中罕见复发,多数cSCC非由致癌性基因融合驱动。

核心结论

  • 研究定义了cSCC进展的基因表达图景,揭示不同亚型细胞亚群异质性,并表明基因融合不是cSCC常见病因。

研究设计与样本

  • 对公开RNA-Seq样本进行荟萃分析,统一处理73例临床正常皮肤、46例光化性角化病、16例原位SCC、13例角化棘皮瘤和147例cSCC样本。

主要发现

  • 个体RNA-Seq研究显示研究特异性聚类且差异基因检测差异大,批次校正后定义了共识差异表达基因集。
  • 单细胞RNA-Seq显示差异表达基因常但非总由肿瘤特异性角质形成细胞表达。
  • 角化棘皮瘤中分化角质形成细胞增多,RDEB-cSCC中肿瘤特异性角质形成细胞最多。
  • 免疫抑制患者cSCC样本较免疫正常者记忆B细胞和CD8+ T细胞减少。
  • cSCC和中间病变阶段中复发超过1%的融合转录本候选极少。

关键数值与推荐

  • 利用GTEx数据提炼出300基因慢性日光暴露特征,证实cSCC进展后期累积紫外线暴露更高。

临床怎么用

  • 为cSCC研究提供可靠资源,并可能有助于研究潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cutaneous squamous cell carcinomas (cSCCs) are the second most common human cancer and have been characterized by RNA sequencing (RNA-Seq); however, the transferability of findings from individual studies may be limited by small sample sizes and diverse analysis protocols. OBJECTIVES: To define the transcriptome landscape at different stages in the progression of normal skin to cSCC via a meta-analysis of publicly available RNA-Seq samples. METHODS: Whole-transcriptome data from 73 clinically normal skin samples, 46 actinic keratoses (AK) samples, 16 in situ SCC samples, 13 keratoacanthoma (KA) samples and 147 cSCC samples [including 30 samples from immunocompromised patients and 8 from individuals with recessive dystrophic epidermolysis bullosa (RDEB)] were uniformly processed to harmonize gene expression. Differential expression, fusion detection and cell-type deconvolution analyses were performed. RESULTS: Individual RNA-Seq studies of cSCC demonstrated study-specific clustering and varied widely in their differential gene expression detection. Following batch correction, we defined a consensus set of differentially expressed genes (DEGs), including those altered in the preinvasive stages of cSCC development, and used single-cell RNA-Seq data to demonstrate that DEGs are often - but not always - expressed by tumour-specific keratinocytes (TSKs). Analysis of the cellular composition of cSCC, KA and RDEB-cSCC identified an increase in differentiated keratinocytes in KA, while RDEB-cSCC contained the most TSKs. Compared with cSCC arising in immunocompetent individuals, cSCC samples from immunosuppressed patients demonstrated fewer memory B cells and CD8+ T cells. A comprehensive and unbiased search for fusion transcripts in cSCC and intermediate disease stages identified few candidates that recurred in >1% of all specimens, suggesting that most cSCC are not driven by oncogenic gene fusions. Finally, using Genotype-Tissue Expression (GTEx) data, we distilled a novel 300-gene signature of chronic sun exposure that affirms greater cumulative ultraviolet (UV) exposure in later stages of cSCC development. CONCLUSIONS: Our results define the gene expression landscape of cSCC progression, characterize cell subpopulation heterogeneity in cSCC subtypes that contribute to their distinct clinical phenotypes, demonstrate that gene fusions are not a common cause of cSCC and identify UV-responsive genes associated with cSCC development. Cutaneous squamous cell carcinoma (‘cSCC’ for short) is a common type of skin cancer. Many studies have used a technology called ‘RNA sequencing’ to look for genes that behave differently from normal in cSCC. These genes may play a role in the development and progression of the disease. Small sample numbers and different methods have made it difficult to compare the results of different studies. This study re-analysed data from 11 other studies, giving a total of 306 cSCC specimens for us to compare. We also examined gene activity (or ‘expression’) in cSCC, as well as at earlier stages in the disease. We found a set of genes that were active during the progression from normal skin to cSCC. In this group, we identified genes controlled by exposure to sunlight, the leading risk factor for the development of skin cancer. We combined our findings with other data to determine which cells are present in the subtypes of cSCC. We found differences in the number of tumour, immune and stromal cells. Finally, we looked at cSCC and intermediate disease stages for ‘gene fusions’ (or ‘hybrid genes’ formed as a result of instability in the genome). These fusions can fuel tumour growth. Most specimens analysed had one gene fusion, but only a few were recurrent or exhibited features that would suggest disease. Our findings provide a reliable resource for researchers. They could also help with investigating potential treatment targets for cSCC.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Bencomo T, Lee CS. Gene expression landscape of cutaneous squamous cell carcinoma progression. Br J Dermatol. 2024. PMID: 38867481. doi:10.1093/bjd/ljae249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。